Exact Mass: 815.6427399999999

Exact Mass Matches: 815.6427399999999

Found 293 metabolites which its exact mass value is equals to given mass value 815.6427399999999, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PC(18:0/20:1(11Z))

(2-{[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-(octadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(18:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/20:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(14:0/24:1(15Z))

trimethyl(2-{[(2R)-2-[(15Z)-tetracos-15-enoyloxy]-3-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C46H90NO8P (815.640371)


PC(14:0/24:1(15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/24:1(15Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(14:1(9Z)/24:0)

trimethyl(2-{[(2R)-2-(tetracosanoyloxy)-3-[(9Z)-tetradec-9-enoyloxy]propyl phosphonato]oxy}ethyl)azanium

C46H90NO8P (815.640371)


PC(14:1(9Z)/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/24:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(16:0/22:1(13Z))

(2-{[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-(hexadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(16:0/22:1(13Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/22:1(13Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of erucic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(16:1(9Z)/22:0)

(2-{[(2R)-2-(docosanoyloxy)-3-[(9Z)-hexadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(16:1(9Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/22:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of behenic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(18:1(11Z)/20:0)

(2-{[(2R)-2-(icosanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(18:1(11Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/20:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(18:1(9Z)/20:0)

(2-{[(2R)-2-(icosanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(18:1(9Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/20:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(20:0/18:1(11Z))

(2-{[(2R)-3-(icosanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(20:0/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/18:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(20:0/18:1(9Z))

(2-{[(2R)-3-(icosanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(20:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/18:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of oleic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(20:1(11Z)/18:0)

(2-{[(2R)-3-[(11Z)-icos-11-enoyloxy]-2-(octadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(20:1(11Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:1(11Z)/18:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of stearic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(22:0/16:1(9Z))

(2-{[(2R)-3-(docosanoyloxy)-2-[(9Z)-hexadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(22:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/16:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(22:1(13Z)/16:0)

(2-{[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-(hexadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(22:1(13Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:1(13Z)/16:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(24:0/14:1(9Z))

trimethyl(2-{[(2R)-3-(tetracosanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propyl phosphonato]oxy}ethyl)azanium

C46H90NO8P (815.640371)


PC(24:0/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:0/14:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(24:1(15Z)/14:0)

trimethyl(2-{[(2R)-3-[(15Z)-tetracos-15-enoyloxy]-2-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C46H90NO8P (815.640371)


PC(24:1(15Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:1(15Z)/14:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of myristic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PE-NMe(16:0/24:1(15Z))

[3-(hexadecanoyloxy)-2-[(15Z)-tetracos-15-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(16:0/24:1(15Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/24:1(15Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(16:1(9Z)/24:0)

{3-[(9Z)-hexadec-9-enoyloxy]-2-(tetracosanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(16:1(9Z)/24:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:1(9Z)/24:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(18:0/22:1(13Z))

{2-[(13Z)-docos-13-enoyloxy]-3-(octadecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(18:0/22:1(13Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/22:1(13Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(18:1(11Z)/22:0)

[2-(docosanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(18:1(11Z)/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(11Z)/22:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(18:1(9Z)/22:0)

[2-(docosanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(18:1(9Z)/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(9Z)/22:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(20:0/20:1(11Z))

{2-[(11Z)-icos-11-enoyloxy]-3-(icosanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(20:0/20:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/20:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(20:1(11Z)/20:0)

{3-[(11Z)-icos-11-enoyloxy]-2-(icosanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(20:1(11Z)/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:1(11Z)/20:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(22:0/18:1(11Z))

[3-(docosanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(22:0/18:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/18:1(11Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of cis-vaccenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(22:0/18:1(9Z))

[3-(docosanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(22:0/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/18:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of oleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(22:1(13Z)/18:0)

{3-[(13Z)-docos-13-enoyloxy]-2-(octadecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(22:1(13Z)/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:1(13Z)/18:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(24:0/16:1(9Z))

{2-[(9Z)-hexadec-9-enoyloxy]-3-(tetracosanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(24:0/16:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(24:0/16:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(24:1(15Z)/16:0)

[2-(hexadecanoyloxy)-3-[(15Z)-tetracos-15-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe(24:1(15Z)/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(24:1(15Z)/16:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(15:0/24:1(15Z))

[2-(dimethylamino)ethoxy][3-(pentadecanoyloxy)-2-[(15Z)-tetracos-15-enoyloxy]propoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe2(15:0/24:1(15Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(15:0/24:1(15Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(24:1(15Z)/15:0)

[2-(dimethylamino)ethoxy][2-(pentadecanoyloxy)-3-[(15Z)-tetracos-15-enoyloxy]propoxy]phosphinic acid

C46H90NO8P (815.640371)


PE-NMe2(24:1(15Z)/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:1(15Z)/15:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

Phosphatidylcholine 20:0-18:1

Phosphatidylcholine 20:0-18:1

C46H90NO8P (815.640371)


   
   

(2R)-2-hydroxy-N-[(2S,3S,4R,16E)-3,4-dihydroxy-1-(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)oxy-16-icosen-2-yl]icosanamide|pakistamide B

(2R)-2-hydroxy-N-[(2S,3S,4R,16E)-3,4-dihydroxy-1-(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)oxy-16-icosen-2-yl]icosanamide|pakistamide B

C46H89NO10 (815.6486134)


   

1-O-beta-D-glucopyranosyl-(2S,3S,4R,9Z)-2-[(2R)-2-hydroxydocosanoylamino]-9-octadecene-1,3,4-triol

1-O-beta-D-glucopyranosyl-(2S,3S,4R,9Z)-2-[(2R)-2-hydroxydocosanoylamino]-9-octadecene-1,3,4-triol

C46H89NO10 (815.6486134)


   

(2S,3S,4R,8Z)-1-O-(beta-D-galactopyranosyl)-2N-[(2R)-2-hydroxy-19(Z)-docosanoylamino]-8(Z)-octadecene-1,3-4-triol

(2S,3S,4R,8Z)-1-O-(beta-D-galactopyranosyl)-2N-[(2R)-2-hydroxy-19(Z)-docosanoylamino]-8(Z)-octadecene-1,3-4-triol

C46H89NO10 (815.6486134)


   

PC 38:1

1-tetradecanoyl-2-(15Z-tetracosenoyl)-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)


Found in mouse brain; TwoDicalId=466; MgfFile=160720_brain_AA_19_Neg; MgfId=1990 Found in mouse heart; TwoDicalId=3434; MgfFile=160902_Heart_EPA_Neg_09; MgfId=1343

   

(2-{[2-(docosanoyloxy)-3-[hexadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

(2-{[2-(docosanoyloxy)-3-[hexadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


   

PC(16:0/22:1)[U]

3,5,8-Trioxa-4-phosphatriacont-21-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxohexadecyl)oxy]methyl]-, inner salt, 4-oxide, (Z)-

C46H90NO8P (815.640371)


   

PC(18:0/20:1)

3,5,8-Trioxa-4-phosphaoctacosen-21-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxooctadecyl)oxy]methyl]-, inner salt, 4-oxide, [R-(Z)]-

C46H90NO8P (815.640371)


   

PC(18:1/20:0)

3,5,8-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxo-9-octadecenyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C46H90NO8P (815.640371)


   

PC(18:1/20:0)[U]

3,5,8-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxo-9-octadecenyl)oxy]methyl]-, inner salt, 4-oxide, (Z)-

C46H90NO8P (815.640371)


   

PC(20:0/18:1)[U]

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, (Z)-

C46H90NO8P (815.640371)


   

PC(20:0/18:1)

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-7-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z)]-

C46H90NO8P (815.640371)


   

Lecithin

1-lignoceroyl-2-myristoleoyl-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)


   

PC(16:0/22:1(11Z))

1-hexadecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphocholine

C46H90NO8P (815.640371)


   

PC(17:1(9Z)/21:0)

1-(9Z-heptadecenoyl)-2-heneicosanoyl-glycero-3-phosphocholine

C46H90NO8P (815.640371)


   

PC(19:0/19:1(9Z))

1-nonadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C46H90NO8P (815.640371)


   

PC(19:1(9Z)/19:0)

1-(9Z-nonadecenoyl)-2-nonadecanoyl-glycero-3-phosphocholine

C46H90NO8P (815.640371)


   

PC(21:0/17:1(9Z))

1-heneicosanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphocholine

C46H90NO8P (815.640371)


   

PC(22:1(11Z)/16:0)

1-(11Z-docosenoyl)-2-hexadecanoyl-glycero-3-phosphocholine

C46H90NO8P (815.640371)


   

PE(19:0/22:1(11Z))

1-nonadecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphoethanolamine

C46H90NO8P (815.640371)


   

PE(19:1(9Z)/22:0)

1-(9Z-nonadecenoyl)-2-docosanoyl-glycero-3-phosphoethanolamine

C46H90NO8P (815.640371)


   

PE(20:1(11Z)/21:0)

1-(11Z-eicosenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

C46H90NO8P (815.640371)


   

PE(21:0/20:1(11Z))

1-heneicosanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine

C46H90NO8P (815.640371)


   

PE(22:0/19:1(9Z))

1-docosanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

C46H90NO8P (815.640371)


   

PE(22:1(11Z)/19:0)

1-(11Z-docosenoyl)-2-nonadecanoyl-glycero-3-phosphoethanolamine

C46H90NO8P (815.640371)


   

PE 41:1

1-heneicosanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine

C46H90NO8P (815.640371)


   

HexCer 40:1;O4

N-(2R-hydroxydocosanoyl)-1-beta-glucosyl-4R-hydroxy-8Z-octadecasphingenine

C46H89NO10 (815.6486134)


   

1-eicosanoyl-2-[(11Z)-octadecenoyl]-sn-glycero-3-phosphocholine

1-eicosanoyl-2-[(11Z)-octadecenoyl]-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)


A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (11Z)-octadecenoyl respectively.

   

[2-[(Z)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] tricosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)


   

[3-tetracosanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-tetracosanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

HexCer 9:0;3O/31:1;(2OH)

HexCer 9:0;3O/31:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 8:0;3O/32:1;(2OH)

HexCer 8:0;3O/32:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 12:0;3O/28:1;(2OH)

HexCer 12:0;3O/28:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 10:0;3O/30:1;(2OH)

HexCer 10:0;3O/30:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 13:0;3O/27:1;(2OH)

HexCer 13:0;3O/27:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 13:1;3O/27:0;(2OH)

HexCer 13:1;3O/27:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 12:1;3O/28:0;(2OH)

HexCer 12:1;3O/28:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 11:0;3O/29:1;(2OH)

HexCer 11:0;3O/29:1;(2OH)

C46H89NO10 (815.6486134)


   

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

C50H89NO5S (815.6461104)


   

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxytetracosane-1-sulfonic acid

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxytetracosane-1-sulfonic acid

C50H89NO5S (815.6461104)


   

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

C50H89NO5S (815.6461104)


   

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

C50H89NO5S (815.6461104)


   

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytetracosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytetracosa-4,8-diene-1-sulfonic acid

C50H89NO5S (815.6461104)


   

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]hexacosane-1-sulfonic acid

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]hexacosane-1-sulfonic acid

C50H89NO5S (815.6461104)


   

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]hexacos-4-ene-1-sulfonic acid

C50H89NO5S (815.6461104)


   

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytetracos-4-ene-1-sulfonic acid

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytetracos-4-ene-1-sulfonic acid

C50H89NO5S (815.6461104)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] octacosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] octacosanoate

C46H90NO8P (815.640371)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-octacos-17-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-octacos-17-enoate

C46H90NO8P (815.640371)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-triacont-19-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-triacont-19-enoate

C46H90NO8P (815.640371)


   

Cer 14:0;2O/19:5;(3OH)(FA 20:5)

Cer 14:0;2O/19:5;(3OH)(FA 20:5)

C53H85NO5 (815.6427399999999)


   

Cer 15:0;2O/18:4;(3OH)(FA 20:6)

Cer 15:0;2O/18:4;(3OH)(FA 20:6)

C53H85NO5 (815.6427399999999)


   

Cer 15:0;2O/22:6;(3OH)(FA 16:4)

Cer 15:0;2O/22:6;(3OH)(FA 16:4)

C53H85NO5 (815.6427399999999)


   

Cer 14:0;2O/20:5;(3OH)(FA 19:5)

Cer 14:0;2O/20:5;(3OH)(FA 19:5)

C53H85NO5 (815.6427399999999)


   

Cer 19:0;2O/18:5;(3OH)(FA 16:5)

Cer 19:0;2O/18:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)


   

Cer 16:0;2O/21:5;(3OH)(FA 16:5)

Cer 16:0;2O/21:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)


   

Cer 18:0;2O/16:5;(3OH)(FA 19:5)

Cer 18:0;2O/16:5;(3OH)(FA 19:5)

C53H85NO5 (815.6427399999999)


   

Cer 15:0;2O/18:5;(3OH)(FA 20:5)

Cer 15:0;2O/18:5;(3OH)(FA 20:5)

C53H85NO5 (815.6427399999999)


   

Cer 17:0;2O/16:4;(3OH)(FA 20:6)

Cer 17:0;2O/16:4;(3OH)(FA 20:6)

C53H85NO5 (815.6427399999999)


   

Cer 17:0;2O/16:5;(3OH)(FA 20:5)

Cer 17:0;2O/16:5;(3OH)(FA 20:5)

C53H85NO5 (815.6427399999999)


   

Cer 18:0;2O/19:5;(3OH)(FA 16:5)

Cer 18:0;2O/19:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)


   

Cer 14:0;2O/20:6;(3OH)(FA 19:4)

Cer 14:0;2O/20:6;(3OH)(FA 19:4)

C53H85NO5 (815.6427399999999)


   

Cer 16:0;2O/19:5;(3OH)(FA 18:5)

Cer 16:0;2O/19:5;(3OH)(FA 18:5)

C53H85NO5 (815.6427399999999)


   

Cer 16:0;2O/16:5;(3OH)(FA 21:5)

Cer 16:0;2O/16:5;(3OH)(FA 21:5)

C53H85NO5 (815.6427399999999)


   

Cer 15:0;2O/22:5;(3OH)(FA 16:5)

Cer 15:0;2O/22:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)


   

Cer 15:0;2O/16:5;(3OH)(FA 22:5)

Cer 15:0;2O/16:5;(3OH)(FA 22:5)

C53H85NO5 (815.6427399999999)


   

Cer 16:0;2O/18:5;(3OH)(FA 19:5)

Cer 16:0;2O/18:5;(3OH)(FA 19:5)

C53H85NO5 (815.6427399999999)


   

Cer 15:0;2O/19:5;(3OH)(FA 19:5)

Cer 15:0;2O/19:5;(3OH)(FA 19:5)

C53H85NO5 (815.6427399999999)


   

Cer 17:0;2O/20:6;(3OH)(FA 16:4)

Cer 17:0;2O/20:6;(3OH)(FA 16:4)

C53H85NO5 (815.6427399999999)


   

Cer 21:0;2O/16:5;(3OH)(FA 16:5)

Cer 21:0;2O/16:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)


   

Cer 17:0;2O/20:5;(3OH)(FA 16:5)

Cer 17:0;2O/20:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)


   

Cer 15:0;2O/16:4;(3OH)(FA 22:6)

Cer 15:0;2O/16:4;(3OH)(FA 22:6)

C53H85NO5 (815.6427399999999)


   

Cer 14:0;2O/18:5;(3OH)(FA 21:5)

Cer 14:0;2O/18:5;(3OH)(FA 21:5)

C53H85NO5 (815.6427399999999)


   

Cer 15:0;2O/20:5;(3OH)(FA 18:5)

Cer 15:0;2O/20:5;(3OH)(FA 18:5)

C53H85NO5 (815.6427399999999)


   

Cer 14:0;2O/19:4;(3OH)(FA 20:6)

Cer 14:0;2O/19:4;(3OH)(FA 20:6)

C53H85NO5 (815.6427399999999)


   

Cer 15:0;2O/20:6;(3OH)(FA 18:4)

Cer 15:0;2O/20:6;(3OH)(FA 18:4)

C53H85NO5 (815.6427399999999)


   

Cer 14:0;2O/21:5;(3OH)(FA 18:5)

Cer 14:0;2O/21:5;(3OH)(FA 18:5)

C53H85NO5 (815.6427399999999)


   

Cer 17:0;2O/18:5;(3OH)(FA 18:5)

Cer 17:0;2O/18:5;(3OH)(FA 18:5)

C53H85NO5 (815.6427399999999)


   

Cer 19:0;2O/16:5;(3OH)(FA 18:5)

Cer 19:0;2O/16:5;(3OH)(FA 18:5)

C53H85NO5 (815.6427399999999)


   

HexCer 22:1;3O/18:0;(2OH)

HexCer 22:1;3O/18:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 28:0;3O/12:1;(2OH)

HexCer 28:0;3O/12:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 19:1;3O/21:0;(2OH)

HexCer 19:1;3O/21:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 16:1;3O/24:0;(2OH)

HexCer 16:1;3O/24:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 24:1;3O/16:0;(2OH)

HexCer 24:1;3O/16:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 26:1;3O/14:0;(2OH)

HexCer 26:1;3O/14:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 19:0;3O/21:1;(2OH)

HexCer 19:0;3O/21:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 16:0;3O/24:1;(2OH)

HexCer 16:0;3O/24:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 23:1;3O/17:0;(2OH)

HexCer 23:1;3O/17:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 21:1;3O/19:0;(2OH)

HexCer 21:1;3O/19:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 25:0;3O/15:1;(2OH)

HexCer 25:0;3O/15:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 15:1;3O/25:0;(2OH)

HexCer 15:1;3O/25:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 20:1;3O/20:0;(2OH)

HexCer 20:1;3O/20:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 26:0;3O/14:1;(2OH)

HexCer 26:0;3O/14:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 17:1;3O/23:0;(2OH)

HexCer 17:1;3O/23:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 15:0;3O/25:1;(2OH)

HexCer 15:0;3O/25:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 21:0;3O/19:1;(2OH)

HexCer 21:0;3O/19:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 22:0;3O/18:1;(2OH)

HexCer 22:0;3O/18:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 14:0;3O/26:1;(2OH)

HexCer 14:0;3O/26:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 24:0;3O/16:1;(2OH)

HexCer 24:0;3O/16:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 18:0;3O/22:1;(2OH)

HexCer 18:0;3O/22:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 27:1;3O/13:0;(2OH)

HexCer 27:1;3O/13:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 14:1;3O/26:0;(2OH)

HexCer 14:1;3O/26:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 18:1;3O/22:0;(2OH)

HexCer 18:1;3O/22:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 25:1;3O/15:0;(2OH)

HexCer 25:1;3O/15:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 17:0;3O/23:1;(2OH)

HexCer 17:0;3O/23:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 20:0;3O/20:1;(2OH)

HexCer 20:0;3O/20:1;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 28:1;3O/12:0;(2OH)

HexCer 28:1;3O/12:0;(2OH)

C46H89NO10 (815.6486134)


   

HexCer 27:0;3O/13:1;(2OH)

HexCer 27:0;3O/13:1;(2OH)

C46H89NO10 (815.6486134)


   

[3-octanoyloxy-2-[(Z)-triacont-19-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-octanoyloxy-2-[(Z)-triacont-19-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-dotriacont-21-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-dotriacont-21-enoate

C46H90NO8P (815.640371)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] hexacosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] hexacosanoate

C46H90NO8P (815.640371)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (Z)-docos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (Z)-docos-13-enoate

C46H90NO8P (815.640371)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] tetracosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] tetracosanoate

C46H90NO8P (815.640371)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-icos-11-enoyl]oxypropyl] henicosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-icos-11-enoyl]oxypropyl] henicosanoate

C46H90NO8P (815.640371)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

C46H90NO8P (815.640371)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

C46H90NO8P (815.640371)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] heptacosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] heptacosanoate

C46H90NO8P (815.640371)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosanoyloxypropan-2-yl] (Z)-henicos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C46H90NO8P (815.640371)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] pentacosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] pentacosanoate

C46H90NO8P (815.640371)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] docosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] docosanoate

C46H90NO8P (815.640371)


   

[3-decanoyloxy-2-[(Z)-octacos-17-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-decanoyloxy-2-[(Z)-octacos-17-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[2-[(Z)-docos-13-enoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-docos-13-enoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[3-icosanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-icosanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[3-docosanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-docosanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[3-pentacosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-pentacosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-henicos-11-enoyl]oxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[3-nonadecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-nonadecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[2-[(Z)-pentadec-9-enoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-pentadec-9-enoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[3-henicosanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-henicosanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[2-[(Z)-tetracos-13-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-tetracos-13-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[3-dodecanoyloxy-2-[(Z)-hexacos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-dodecanoyloxy-2-[(Z)-hexacos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2S)-3-tetracosanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-tetracosanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-2-icosanoyloxy-3-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-icosanoyloxy-3-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[(E)-pentadec-9-enoyl]oxy-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-pentadec-9-enoyl]oxy-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-nonadecanoyloxypropyl] (E)-docos-13-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-nonadecanoyloxypropyl] (E)-docos-13-enoate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] hexacosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] hexacosanoate

C46H90NO8P (815.640371)


   

[(2R)-2-tetracosanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-tetracosanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-7-enoyl]oxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-7-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-11-enoyl]oxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-11-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-hexacos-5-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-hexacos-5-enoate

C46H90NO8P (815.640371)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] hexacosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] hexacosanoate

C46H90NO8P (815.640371)


   

[(2R)-3-icosanoyloxy-2-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-icosanoyloxy-2-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-2-docosanoyloxy-3-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-docosanoyloxy-3-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-tetracos-15-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-tetracos-15-enoate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-9-enoyl]oxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-9-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)


   

[(2S)-3-docosanoyloxy-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-docosanoyloxy-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (E)-docos-13-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (E)-docos-13-enoate

C46H90NO8P (815.640371)


   

[(2R)-2-[(E)-tetracos-15-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-tetracos-15-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)


   

[(2R)-3-icosanoyloxy-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-icosanoyloxy-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] pentacosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] pentacosanoate

C46H90NO8P (815.640371)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] tetracosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] tetracosanoate

C46H90NO8P (815.640371)


   

[(2R)-2-icosanoyloxy-3-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-icosanoyloxy-3-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-icosanoyloxy-2-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-icosanoyloxy-2-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-2-henicosanoyloxy-3-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-henicosanoyloxy-3-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)


   

[(2R)-3-icosanoyloxy-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-icosanoyloxy-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2S)-3-docosanoyloxy-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-docosanoyloxy-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] pentacosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] pentacosanoate

C46H90NO8P (815.640371)


   

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-13-enoyl]oxypropan-2-yl] henicosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-13-enoyl]oxypropan-2-yl] henicosanoate

C46H90NO8P (815.640371)


   

[(2R)-3-[(E)-icos-13-enoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-icos-13-enoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-icosanoyloxy-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-icosanoyloxy-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-icosanoyloxy-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-icosanoyloxy-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-11-enoyl]oxypropyl] henicosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-11-enoyl]oxypropyl] henicosanoate

C46H90NO8P (815.640371)


   

[(2S)-3-henicosanoyloxy-2-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-henicosanoyloxy-2-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-2-icosanoyloxy-3-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-icosanoyloxy-3-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)


   

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-2-docosanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-docosanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-4-enoyl]oxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-4-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)


   

[(2R)-2-icosanoyloxy-3-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-icosanoyloxy-3-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-hexacos-5-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-hexacos-5-enoate

C46H90NO8P (815.640371)


   

[(2R)-3-dodecanoyloxy-2-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-dodecanoyloxy-2-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] tetracosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] tetracosanoate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-13-enoyl]oxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-13-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)


   

[(2S)-3-[(E)-docos-13-enoyl]oxy-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-[(E)-docos-13-enoyl]oxy-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-octadec-17-enoyloxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-octadec-17-enoyloxypropyl] tricosanoate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-13-enoyl]oxypropyl] henicosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-13-enoyl]oxypropyl] henicosanoate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadec-17-enoyloxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadec-17-enoyloxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)


   

[(2R)-2-icosanoyloxy-3-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-icosanoyloxy-3-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)


   

[(2R)-2-icosanoyloxy-3-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-icosanoyloxy-3-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2S)-2-dodecanoyloxy-3-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-dodecanoyloxy-3-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] pentacosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] pentacosanoate

C46H90NO8P (815.640371)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] pentacosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] pentacosanoate

C46H90NO8P (815.640371)


   

[(2S)-3-[(E)-tetracos-15-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-[(E)-tetracos-15-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-3-[(E)-icos-11-enoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-icos-11-enoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-11-enoyl]oxypropan-2-yl] henicosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-11-enoyl]oxypropan-2-yl] henicosanoate

C46H90NO8P (815.640371)


   

[(2R)-3-icosanoyloxy-2-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-icosanoyloxy-2-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-6-enoyl]oxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-6-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)


   

1-tetradecanoyl-2-[(15Z)-tetracosenoyl]-sn-glycero-3-phosphocholine

1-tetradecanoyl-2-[(15Z)-tetracosenoyl]-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)


A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are tetradecanoyl and (15Z)-tetracosenoyl respectively.

   

1-octadecanoyl-2-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine

1-octadecanoyl-2-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)


A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (11Z)-eicosenoyl respectively.

   

1-hexadecanoyl-2-[(13Z)-docosenoyl]-sn-glycero-3-phosphocholine

1-hexadecanoyl-2-[(13Z)-docosenoyl]-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)


A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and (13Z)-docosenoyl respectively.

   

1-[(9Z)-octadecenoyl]-2-eicosanoyl-sn-glycero-3-phosphocholine

1-[(9Z)-octadecenoyl]-2-eicosanoyl-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)


A phosphatidylcholine 38:1 in which the acyl groups at positions 1 and 2 are specified as (9Z)-octadecenoyl and eicosanoyl respectively.

   

1-eicosanoyl-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine

1-eicosanoyl-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)


A phosphatidylcholine 38:1 in which the acyl groups at positions 1 and 2 are eicosanoyl and (9Z)-octadecenoyl respectively.

   

PE-NMe(16:0/24:1(15Z))

PE-NMe(16:0/24:1(15Z))

C46H90NO8P (815.640371)


   

phosphatidylcholine 38:1

phosphatidylcholine 38:1

C46H90NO8P (815.640371)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 38 carbons in total with 1 double bond.

   

phosphatidylcholine (18:1/20:0)

phosphatidylcholine (18:1/20:0)

C46H90NO8P (815.640371)


A phosphatidylcholine 38:1 in which the fatty acyl groups at positions 1 and 2 are specified as C18:1 and C20:0 respectively.

   

MePC(37:1)

MePC(16:1_21:0)

C46H90NO8P (815.640371)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(39:1)

dMePE(16:1_23:0)

C46H90NO8P (815.640371)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(40:1)

Hex1Cer(t18:1_22:0(1+O))

C46H89NO10 (815.6486134)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(2r)-n-[(2s,3s,4r,8z)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-8-en-2-yl]-2-hydroxydocosanimidic acid

(2r)-n-[(2s,3s,4r,8z)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-8-en-2-yl]-2-hydroxydocosanimidic acid

C46H89NO10 (815.6486134)


   

(2r)-n-[(2s,3s,4r,8z)-3,4-dihydroxy-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-8-en-2-yl]-2-hydroxydocosanimidic acid

(2r)-n-[(2s,3s,4r,8z)-3,4-dihydroxy-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-8-en-2-yl]-2-hydroxydocosanimidic acid

C46H89NO10 (815.6486134)